These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 17412849

  • 1. Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia.
    Shi L, Ascher-Svanum H, Zhu B, Faries D, Montgomery W, Marder SR.
    Psychiatr Serv; 2007 Apr; 58(4):482-8. PubMed ID: 17412849
    [Abstract] [Full Text] [Related]

  • 2. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L, Jaffe A, Levine J.
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Time to discontinuation of depot and oral first-generation antipsychotics in the usual care of schizophrenia.
    Zhu B, Ascher-Svanum H, Shi L, Faries D, Montgomery W, Marder SR.
    Psychiatr Serv; 2008 Mar; 59(3):315-7. PubMed ID: 18308914
    [Abstract] [Full Text] [Related]

  • 5. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia.
    Valenstein M, Copeland LA, Owen R, Blow FC, Visnic S.
    J Clin Psychiatry; 2001 Jul; 62(7):545-51. PubMed ID: 11488366
    [Abstract] [Full Text] [Related]

  • 6. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
    Marcus SC, Zummo J, Pettit AR, Stoddard J, Doshi JA.
    J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
    [Abstract] [Full Text] [Related]

  • 7. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.
    Encephale; 2005 Sep; 31(2):235-46. PubMed ID: 15959450
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rehospitalization risk with second-generation and depot antipsychotics.
    Conley RR, Kelly DL, Love RC, McMahon RP.
    Ann Clin Psychiatry; 2003 Mar; 15(1):23-31. PubMed ID: 12839430
    [Abstract] [Full Text] [Related]

  • 10. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M, Osman E.
    Turk Psikiyatri Derg; 2022 Mar; 33(2):146-148. PubMed ID: 35730516
    [Abstract] [Full Text] [Related]

  • 11. Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review.
    Uchida T, Suzuki T, Sakurai H, Tsutsumi C, Den R, Mimura M, Uchida H.
    Int Clin Psychopharmacol; 2013 Sep; 28(5):261-6. PubMed ID: 23820334
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Depot bromperidol decanoate for schizophrenia.
    Wong D, Adams CE, David A, Quraishi SN.
    Cochrane Database Syst Rev; 2004 Sep; (3):CD001719. PubMed ID: 15266450
    [Abstract] [Full Text] [Related]

  • 14. Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns.
    Kreyenbuhl JA, Valenstein M, McCarthy JF, Ganoczy D, Blow FC.
    Psychiatr Serv; 2007 Apr; 58(4):489-95. PubMed ID: 17412850
    [Abstract] [Full Text] [Related]

  • 15. Who receives long-acting antipsychotic medications?
    Glazer WM.
    Psychiatr Serv; 2007 Apr; 58(4):437. PubMed ID: 17412839
    [No Abstract] [Full Text] [Related]

  • 16. Excessive antipsychotic dosing in 2 U.S. State hospitals.
    Diaz FJ, De Leon J.
    J Clin Psychiatry; 2002 Nov; 63(11):998-1003. PubMed ID: 12444813
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Depot haloperidol decanoate for schizophrenia.
    Quraishi S, David A.
    Cochrane Database Syst Rev; 2000 Nov; 1999(2):CD001361. PubMed ID: 10796438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.